CLN5
MCID: CRD184
MIFTS: 42

Ceroid Lipofuscinosis, Neuronal, 5 (CLN5)

Categories: Eye diseases, Genetic diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Ceroid Lipofuscinosis, Neuronal, 5

MalaCards integrated aliases for Ceroid Lipofuscinosis, Neuronal, 5:

Name: Ceroid Lipofuscinosis, Neuronal, 5 57 75 13 73
Neuronal Ceroid Lipofuscinosis 5 12 53 25 15
Cln5 57 12 53 75
Finnish Variant Late Infantile Neuronal Ceroid Lipofuscinosis 25 75
Ceroid Lipofuscinosis Neuronal 5 29 6
Cln5 Disease 25 59
Vlincl 25 75
Neuronal Ceroid Lipofuscinosis 5 with Variable Age at Onset 75
Ceroid Lipofuscinosis, Neuronal, 5, Variable Age at Onset 57
Neuronal Ceroid Lipofuscinosis 5 Variable Age of Onset 12
Neuronal Ceroid Lipofuscinosis Finnish Variant 53
Neuronal Ceroid Lipofuscinosis, Late-Infantile 25
Late-Infantile Neuronal Ceroid Lipofuscinosis 25
Late-Infantile Neuronal Ceroid Lipfuscinosis 73
Lipofuscinosis, Ceroid, Neuronal, Type 5 40
Ceroid Lipofuscinosis, Neuronal, 6 73
Cln5 Disease, Late Infantile 53
Jansky-Bielschowsky Disease 25
Cln5 Disease, Juvenile 53
Cln5 Disease, Adult 53
Finnish Vlincl 25
Finnish 75

Characteristics:

Orphanet epidemiological data:

59
cln5 disease
Inheritance: Autosomal recessive; Age of onset: Childhood;

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
onset at 4 to 7 years
later onset can also occur (up to age 17 years)
death at 13 to 30 years
one family with late-adult onset and cerebellar ataxia has been reported (last curated february 2015)


HPO:

32
ceroid lipofuscinosis, neuronal, 5:
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 57 256731
Disease Ontology 12 DOID:0110728
ICD10 33 E75.4
Orphanet 59 ORPHA228360
ICD10 via Orphanet 34 E75.4
UMLS via Orphanet 74 C1850442
MedGen 42 C1850442
MeSH 44 D009472

Summaries for Ceroid Lipofuscinosis, Neuronal, 5

Genetics Home Reference : 25 CLN5 disease is an inherited disorder that primarily affects the nervous system. The signs and symptoms of this condition can begin anytime between childhood and early adulthood, but they typically appear around age 5. Children with CLN5 disease often have normal development until they experience the first signs of the condition, which are usually problems with movement and a loss of previously acquired motor skills (developmental regression). Other features of the condition include recurrent seizures that involve uncontrollable muscle jerks (myoclonic epilepsy), difficulty coordinating movements (ataxia), vision loss, and a decline in intellectual function. The life expectancy of people with CLN5 disease varies; affected individuals usually survive into adolescence or mid-adulthood.

MalaCards based summary : Ceroid Lipofuscinosis, Neuronal, 5, also known as neuronal ceroid lipofuscinosis 5, is related to neuronal ceroid lipofuscinosis and ceroid lipofuscinosis, neuronal, 2, and has symptoms including seizures, ataxia and myoclonus. An important gene associated with Ceroid Lipofuscinosis, Neuronal, 5 is CLN5 (CLN5, Intracellular Trafficking Protein). Affiliated tissues include brain, eye and lung, and related phenotypes are nystagmus and intellectual disability

Disease Ontology : 12 A neuronal ceroid lipofuscinosis that is characterized by lipopigment patterns with mixed combinations of 'granular,' 'curvilinear,' and 'fingerprint' profiles, progressive dementia, seizures, and progressive visual failure and has material basis in homozygous or compound heterozygous mutation in the CLN5 gene on chromosome 13q22.

NIH Rare Diseases : 53 Neuronal ceroid lipofuscinosis 5 (CLN5-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition generally develop between ages 4.5 and 7 years, although later onset cases have been reported. Affected people may experience loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and cognitive/motor decline. It occurs predominantly in the Finnish population. CLN5-NCL is caused by changes (mutations) in the CLN5 gene and is inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.

OMIM : 57 The neuronal ceroid lipofuscinoses (NCL; CLN) are a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by the intracellular accumulation of autofluorescent lipopigment storage material in different patterns ultrastructurally. The lipopigment patterns observed most often in CLN5 comprise mixed combinations of 'granular,' 'curvilinear,' and 'fingerprint' profiles. The clinical course includes progressive dementia, seizures, and progressive visual failure (Mole et al., 2005). For a general phenotypic description and a discussion of genetic heterogeneity of CLN, see CLN1 (256730). (256731)

UniProtKB/Swiss-Prot : 75 Ceroid lipofuscinosis, neuronal, 5: A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 5 comprise mixed combinations of granular, curvilinear, and fingerprint profiles.

Related Diseases for Ceroid Lipofuscinosis, Neuronal, 5

Diseases in the Neuronal Ceroid Lipofuscinosis family:

Ceroid Lipofuscinosis, Neuronal, 4b, Autosomal Dominant Ceroid Lipofuscinosis, Neuronal, 3
Ceroid Lipofuscinosis, Neuronal, 4a, Autosomal Recessive Ceroid Lipofuscinosis, Neuronal, 2
Ceroid Lipofuscinosis, Neuronal, 1 Ceroid Lipofuscinosis, Neuronal, 5
Ceroid Lipofuscinosis, Neuronal, 8 Ceroid Lipofuscinosis, Neuronal, 6
Ceroid Lipofuscinosis, Neuronal, 9 Ceroid Lipofuscinosis, Neuronal, 10
Ceroid Lipofuscinosis, Neuronal, 7 Ceroid Lipofuscinosis, Neuronal, 11
Ceroid Lipofuscinosis, Neuronal, 13 Adult Neuronal Ceroid Lipofuscinosis

Diseases related to Ceroid Lipofuscinosis, Neuronal, 5 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 447)
# Related Disease Score Top Affiliating Genes
1 neuronal ceroid lipofuscinosis 29.8 CLN5 FBXL3
2 ceroid lipofuscinosis, neuronal, 2 12.6
3 amyloidosis, finnish type 12.5
4 congenital nephrotic syndrome finnish type 12.5
5 familial amyloidosis, finnish type 12.4
6 salla disease 12.0
7 epilepsy mental deterioration finnish type 12.0
8 gracile syndrome 11.9
9 nephrotic syndrome, type 1 11.7
10 neuronal ceroid-lipofuscinoses 11.6
11 diarrhea 1, secretory chloride, congenital 11.5
12 ceroid lipofuscinosis, neuronal, 6 11.5
13 aspartylglucosaminuria 11.5
14 ceroid storage disease 11.4
15 nephrotic syndrome 11.4
16 familial nephrotic syndrome 11.4
17 cartilage-hair hypoplasia 11.3
18 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 11.3
19 rapadilino syndrome 11.3
20 lethal congenital contracture syndrome 1 11.3
21 tibial muscular dystrophy, tardive 11.3
22 tibial muscular dystrophy 11.3
23 sialuria 11.2
24 congenital chloride diarrhea 11.2
25 megaloblastic anemia 1 11.2
26 peho syndrome 11.1
27 lethal congenital contracture syndrome 11.1
28 ceroid lipofuscinosis, neuronal, 9 11.1
29 ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant 11.1
30 ceroid lipofuscinosis, neuronal, 10 11.1
31 ceroid lipofuscinosis, neuronal, 7 11.1
32 ceroid lipofuscinosis, neuronal, 11 11.1
33 ceroid lipofuscinosis, neuronal, 13 11.1
34 free sialic acid storage disorders 11.1
35 lattice corneal dystrophy type ii 11.1
36 amyloidosis, hereditary, transthyretin-related 11.0
37 bone dysplasia, lethal, holmgren type 11.0
38 mitochondrial dna depletion syndrome 7 11.0
39 lipid storage disease 11.0
40 fundus dystrophy, pseudoinflammatory, recessive form 10.9
41 infantile sialic acid storage disease 10.9
42 myopathy, distal, 3 10.9
43 lattice corneal dystrophy 10.9
44 pseudoinflammatory fundus dystrophy 10.9
45 ceroid lipofuscinosis, neuronal, 3 10.4
46 ceroid lipofuscinosis, neuronal, 1 10.4
47 amyloidosis 10.3
48 spinocerebellar ataxia 7 10.3
49 spinocerebellar ataxia, autosomal recessive 7 10.3
50 autosomal dominant cerebellar ataxia 10.3

Graphical network of the top 20 diseases related to Ceroid Lipofuscinosis, Neuronal, 5:



Diseases related to Ceroid Lipofuscinosis, Neuronal, 5

Symptoms & Phenotypes for Ceroid Lipofuscinosis, Neuronal, 5

Symptoms via clinical synopsis from OMIM:

57
Neurologic Central Nervous System:
seizures
ataxia
developmental regression
myoclonus
motor deterioration
more
Laboratory Abnormalities:
'fingerprint' profiles ultrastructurally
'curvilinear' profiles ultrastructurally
'rectilinear' profiles ultrastructurally

Head And Neck Eyes:
retinal degeneration
vision loss, progressive
nystagmus (1 family)

Neurologic Behavioral Psychiatric Manifestations:
concentration difficulties


Clinical features from OMIM:

256731

Human phenotypes related to Ceroid Lipofuscinosis, Neuronal, 5:

32 (show all 19)
# Description HPO Frequency HPO Source Accession
1 nystagmus 32 occasional (7.5%) HP:0000639
2 intellectual disability 32 HP:0001249
3 seizures 32 HP:0001250
4 ataxia 32 HP:0001251
5 dysarthria 32 occasional (7.5%) HP:0001260
6 developmental regression 32 HP:0002376
7 progressive visual loss 32 HP:0000529
8 myoclonus 32 HP:0001336
9 motor deterioration 32 HP:0002333
10 dysmetria 32 occasional (7.5%) HP:0001310
11 clumsiness 32 HP:0002312
12 dysdiadochokinesis 32 occasional (7.5%) HP:0002075
13 cerebellar atrophy 32 occasional (7.5%) HP:0001272
14 retinal degeneration 32 HP:0000546
15 increased neuronal autofluorescent lipopigment 32 HP:0002074
16 curvilinear intracellular accumulation of autofluorescent lipopigment storage material 32 HP:0003205
17 fingerprint intracellular accumulation of autofluorescent lipopigment storage material 32 HP:0003208
18 rectilinear intracellular accumulation of autofluorescent lipopigment storage material 32 HP:0003226
19 abnormal nervous system electrophysiology 32 HP:0001311

UMLS symptoms related to Ceroid Lipofuscinosis, Neuronal, 5:


seizures, ataxia, myoclonus, clumsiness

Drugs & Therapeutics for Ceroid Lipofuscinosis, Neuronal, 5

Search Clinical Trials , NIH Clinical Center for Ceroid Lipofuscinosis, Neuronal, 5

Genetic Tests for Ceroid Lipofuscinosis, Neuronal, 5

Genetic tests related to Ceroid Lipofuscinosis, Neuronal, 5:

# Genetic test Affiliating Genes
1 Ceroid Lipofuscinosis Neuronal 5 29 CLN5

Anatomical Context for Ceroid Lipofuscinosis, Neuronal, 5

MalaCards organs/tissues related to Ceroid Lipofuscinosis, Neuronal, 5:

41
Brain, Eye, Lung, Liver, Bone, Heart, Prostate

Publications for Ceroid Lipofuscinosis, Neuronal, 5

Articles related to Ceroid Lipofuscinosis, Neuronal, 5:

# Title Authors Year
1
Neuronal ceroid lipofuscinosis in Qatar: report of a novel mutation in ceroid-lipofuscinosis, neuronal 5 in the Arab population. ( 21447811 )
2011

Variations for Ceroid Lipofuscinosis, Neuronal, 5

UniProtKB/Swiss-Prot genetic disease variations for Ceroid Lipofuscinosis, Neuronal, 5:

75 (show all 12)
# Symbol AA change Variation ID SNP ID
1 CLN5 p.Asp230Asn VAR_005137 rs28940280
2 CLN5 p.Arg63His VAR_042700 rs104894386
3 CLN5 p.Tyr209Asp VAR_042701 rs386833981
4 CLN5 p.Arg63Pro VAR_042702 rs104894386
5 CLN5 p.Trp330Cys VAR_059032 rs386833968
6 CLN5 p.Cys77Tyr VAR_066896 rs267606738
7 CLN5 p.Asn143Ser VAR_066897 rs386833975
8 CLN5 p.Leu149Pro VAR_066898 rs386833976
9 CLN5 p.Pro156Ser VAR_066899 rs386833977
10 CLN5 p.Trp158Arg VAR_066900 rs147065248
11 CLN5 p.Trp158Ser VAR_066901 rs386833978
12 CLN5 p.Tyr325Cys VAR_066903 rs148862100

ClinVar genetic disease variations for Ceroid Lipofuscinosis, Neuronal, 5:

6 (show top 50) (show all 144)
# Gene Variation Type Significance SNP ID Assembly Location
1 CLN5 NM_006493.2(CLN5): c.1175_1176delAT (p.Tyr392Terfs) deletion Pathogenic rs386833969 GRCh37 Chromosome 13, 77575055: 77575056
2 CLN5 NM_006493.2(CLN5): c.1175_1176delAT (p.Tyr392Terfs) deletion Pathogenic rs386833969 GRCh38 Chromosome 13, 77000920: 77000921
3 CLN5 NM_006493.2(CLN5): c.225G> A (p.Trp75Ter) single nucleotide variant Pathogenic rs104894385 GRCh37 Chromosome 13, 77566311: 77566311
4 CLN5 NM_006493.2(CLN5): c.225G> A (p.Trp75Ter) single nucleotide variant Pathogenic rs104894385 GRCh38 Chromosome 13, 76992176: 76992176
5 CLN5 NM_006493.2(CLN5): c.835G> A (p.Asp279Asn) single nucleotide variant Pathogenic rs28940280 GRCh37 Chromosome 13, 77574715: 77574715
6 CLN5 NM_006493.2(CLN5): c.835G> A (p.Asp279Asn) single nucleotide variant Pathogenic rs28940280 GRCh38 Chromosome 13, 77000580: 77000580
7 CLN5 NM_006493.2(CLN5): c.335G> A (p.Arg112His) single nucleotide variant Uncertain significance rs104894386 GRCh37 Chromosome 13, 77569212: 77569212
8 CLN5 NM_006493.2(CLN5): c.335G> A (p.Arg112His) single nucleotide variant Uncertain significance rs104894386 GRCh38 Chromosome 13, 76995077: 76995077
9 CLN5 NM_006493.2(CLN5): c.1054G> T (p.Glu352Ter) single nucleotide variant Likely pathogenic rs121908292 GRCh37 Chromosome 13, 77574934: 77574934
10 CLN5 NM_006493.2(CLN5): c.1054G> T (p.Glu352Ter) single nucleotide variant Likely pathogenic rs121908292 GRCh38 Chromosome 13, 77000799: 77000799
11 CLN5 NM_006493.2(CLN5): c.377G> A (p.Cys126Tyr) single nucleotide variant Pathogenic rs267606738 GRCh37 Chromosome 13, 77569254: 77569254
12 CLN5 NM_006493.2(CLN5): c.377G> A (p.Cys126Tyr) single nucleotide variant Pathogenic rs267606738 GRCh38 Chromosome 13, 76995119: 76995119
13 CLN5 NM_006493.2(CLN5): c.1121A> G (p.Tyr374Cys) single nucleotide variant Conflicting interpretations of pathogenicity rs148862100 GRCh37 Chromosome 13, 77575001: 77575001
14 CLN5 NM_006493.2(CLN5): c.1121A> G (p.Tyr374Cys) single nucleotide variant Conflicting interpretations of pathogenicity rs148862100 GRCh38 Chromosome 13, 77000866: 77000866
15 CLN5 NM_006493.2(CLN5): c.713-42_*46del600 deletion Pathogenic GRCh38 Chromosome 13, 77000416: 77001015
16 CLN5 NM_006493.2(CLN5): c.713-42_*46del600 deletion Pathogenic GRCh37 Chromosome 13, 77574551: 77575150
17 CLN5 NM_006493.2(CLN5): c.335G> C (p.Arg112Pro) single nucleotide variant Likely pathogenic rs104894386 GRCh37 Chromosome 13, 77569212: 77569212
18 CLN5 NM_006493.2(CLN5): c.335G> C (p.Arg112Pro) single nucleotide variant Likely pathogenic rs104894386 GRCh38 Chromosome 13, 76995077: 76995077
19 CLN5 NM_006493.2(CLN5): c.433C> T (p.Arg145Ter) single nucleotide variant Likely pathogenic rs386833971 GRCh37 Chromosome 13, 77569310: 77569310
20 CLN5 NM_006493.2(CLN5): c.291dupC (p.Ser98Leufs) duplication Likely pathogenic rs386833970 GRCh38 Chromosome 13, 76992242: 76992242
21 CLN5 NM_006493.2(CLN5): c.1026C> A (p.Tyr342Ter) single nucleotide variant Likely pathogenic rs386833963 GRCh37 Chromosome 13, 77574906: 77574906
22 CLN5 NM_006493.2(CLN5): c.1026C> A (p.Tyr342Ter) single nucleotide variant Likely pathogenic rs386833963 GRCh38 Chromosome 13, 77000771: 77000771
23 CLN5 NM_006493.2(CLN5): c.1071_1072delCT (p.Leu358Alafs) deletion Pathogenic rs386833964 GRCh37 Chromosome 13, 77574951: 77574952
24 CLN5 NM_006493.2(CLN5): c.1071_1072delCT (p.Leu358Alafs) deletion Pathogenic rs386833964 GRCh38 Chromosome 13, 77000816: 77000817
25 CLN5 NM_006493.2(CLN5): c.1072_1073delTT (p.Leu358Alafs) deletion Likely pathogenic rs386833965 GRCh37 Chromosome 13, 77574952: 77574953
26 CLN5 NM_006493.2(CLN5): c.1072_1073delTT (p.Leu358Alafs) deletion Likely pathogenic rs386833965 GRCh38 Chromosome 13, 77000817: 77000818
27 CLN5 NM_006493.2(CLN5): c.1083delT (p.Phe361Leufs) deletion Likely pathogenic rs386833966 GRCh37 Chromosome 13, 77574963: 77574963
28 CLN5 NM_006493.2(CLN5): c.1083delT (p.Phe361Leufs) deletion Likely pathogenic rs386833966 GRCh38 Chromosome 13, 77000828: 77000828
29 CLN5 NM_006493.2(CLN5): c.1103_1106delAACA (p.Lys368Serfs) deletion Pathogenic rs386833967 GRCh37 Chromosome 13, 77574983: 77574986
30 CLN5 NM_006493.2(CLN5): c.1103_1106delAACA (p.Lys368Serfs) deletion Pathogenic rs386833967 GRCh38 Chromosome 13, 77000848: 77000851
31 CLN5 NM_006493.2(CLN5): c.1137G> T (p.Trp379Cys) single nucleotide variant Likely pathogenic rs386833968 GRCh37 Chromosome 13, 77575017: 77575017
32 CLN5 NM_006493.2(CLN5): c.1137G> T (p.Trp379Cys) single nucleotide variant Likely pathogenic rs386833968 GRCh38 Chromosome 13, 77000882: 77000882
33 CLN5 NM_006493.2(CLN5): c.291dupC (p.Ser98Leufs) duplication Likely pathogenic rs386833970 GRCh37 Chromosome 13, 77566377: 77566377
34 CLN5 NM_006493.2(CLN5): c.433C> T (p.Arg145Ter) single nucleotide variant Likely pathogenic rs386833971 GRCh38 Chromosome 13, 76995175: 76995175
35 CLN5 NM_006493.2(CLN5): c.486+5G> C single nucleotide variant Likely pathogenic rs202146713 GRCh37 Chromosome 13, 77569368: 77569368
36 CLN5 NM_006493.2(CLN5): c.486+5G> C single nucleotide variant Likely pathogenic rs202146713 GRCh38 Chromosome 13, 76995233: 76995233
37 CLN5 NM_006493.2(CLN5): c.524T> G (p.Leu175Ter) single nucleotide variant Pathogenic/Likely pathogenic rs386833972 GRCh37 Chromosome 13, 77570074: 77570074
38 CLN5 NM_006493.2(CLN5): c.524T> G (p.Leu175Ter) single nucleotide variant Pathogenic/Likely pathogenic rs386833972 GRCh38 Chromosome 13, 76995939: 76995939
39 CLN5 NM_006493.2(CLN5): c.527_528insA (p.Gly177Trpfs) insertion Likely pathogenic rs386833973 GRCh37 Chromosome 13, 77570077: 77570078
40 CLN5 NM_006493.2(CLN5): c.527_528insA (p.Gly177Trpfs) insertion Likely pathogenic rs386833973 GRCh38 Chromosome 13, 76995942: 76995943
41 CLN5 NM_006493.2(CLN5): c.565C> T (p.Gln189Ter) single nucleotide variant Likely pathogenic rs386833974 GRCh37 Chromosome 13, 77570115: 77570115
42 CLN5 NM_006493.2(CLN5): c.565C> T (p.Gln189Ter) single nucleotide variant Likely pathogenic rs386833974 GRCh38 Chromosome 13, 76995980: 76995980
43 CLN5 NM_006493.2(CLN5): c.575A> G (p.Asn192Ser) single nucleotide variant Likely pathogenic rs386833975 GRCh37 Chromosome 13, 77570125: 77570125
44 CLN5 NM_006493.2(CLN5): c.575A> G (p.Asn192Ser) single nucleotide variant Likely pathogenic rs386833975 GRCh38 Chromosome 13, 76995990: 76995990
45 CLN5 NM_006493.2(CLN5): c.593T> C (p.Leu198Pro) single nucleotide variant Likely pathogenic rs386833976 GRCh37 Chromosome 13, 77570143: 77570143
46 CLN5 NM_006493.2(CLN5): c.593T> C (p.Leu198Pro) single nucleotide variant Likely pathogenic rs386833976 GRCh38 Chromosome 13, 76996008: 76996008
47 CLN5 NM_006493.2(CLN5): c.613C> T (p.Pro205Ser) single nucleotide variant Likely pathogenic rs386833977 GRCh37 Chromosome 13, 77570163: 77570163
48 CLN5 NM_006493.2(CLN5): c.613C> T (p.Pro205Ser) single nucleotide variant Likely pathogenic rs386833977 GRCh38 Chromosome 13, 76996028: 76996028
49 CLN5 NM_006493.2(CLN5): c.620G> C (p.Trp207Ser) single nucleotide variant Likely pathogenic rs386833978 GRCh37 Chromosome 13, 77570170: 77570170
50 CLN5 NM_006493.2(CLN5): c.620G> C (p.Trp207Ser) single nucleotide variant Likely pathogenic rs386833978 GRCh38 Chromosome 13, 76996035: 76996035

Expression for Ceroid Lipofuscinosis, Neuronal, 5

Search GEO for disease gene expression data for Ceroid Lipofuscinosis, Neuronal, 5.

Pathways for Ceroid Lipofuscinosis, Neuronal, 5

GO Terms for Ceroid Lipofuscinosis, Neuronal, 5

Sources for Ceroid Lipofuscinosis, Neuronal, 5

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....